Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 2
1998 3
2000 7
2001 5
2002 6
2003 2
2004 2
2005 5
2006 6
2007 6
2008 8
2009 10
2010 7
2011 2
2012 2
2013 2
2014 8
2015 11
2016 7
2017 1
2018 12
2019 8
2020 9
2021 16
2022 17
2023 16
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Results by year

Filters applied: . Clear all
Page 1
Panitumumab-induced trichomegaly.
Sütcüoğlu O, Özet A. Sütcüoğlu O, et al. Among authors: ozet a. Curr Probl Cancer. 2021 Dec;45(6):100748. doi: 10.1016/j.currproblcancer.2021.100748. Epub 2021 Apr 23. Curr Probl Cancer. 2021. PMID: 33933278 No abstract available.
Bone marrow involvement in breast cancer.
Sütcüoğlu O, Özdemir N, Yazıcı O, Özet A. Sütcüoğlu O, et al. Among authors: ozet a. Curr Probl Cancer. 2022 Feb;46(1):100785. doi: 10.1016/j.currproblcancer.2021.100785. Epub 2021 Aug 15. Curr Probl Cancer. 2022. PMID: 34417058 No abstract available.
Brigatinib-induced tuberculosis reactivation: A case report.
Keş V, Sütcüoğlu O, Gürler F, Yazıcı O, Özet A. Keş V, et al. Among authors: ozet a. Curr Probl Cancer. 2021 Dec;45(6):100738. doi: 10.1016/j.currproblcancer.2021.100738. Epub 2021 Apr 10. Curr Probl Cancer. 2021. PMID: 33867154
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.
Gürler F, Tay F, Sucuoğlu İşleyen Z, Yerlikaya T, Hendem E, Esen SA, Sütçüoğlu O, Işık D, Niğdelioğlu B, Özen M, Şahin E, Şakalar T, Şengül Samancı N, Alan Ö, Hacıbekiroğlu İ, Algın E, Yılmaz MK, Türk HM, Öksüzoğlu B, Yavuz A, Yüksel O, Bora H, Yazıcı O, Özet A, Özdemir N. Gürler F, et al. Among authors: ozet a. Cancer Med. 2024 Jul;13(14):e70002. doi: 10.1002/cam4.70002. Cancer Med. 2024. PMID: 39030808 Free PMC article.
Niraparib-induced pure red cell aplasia.
Bir Yücel K, Yıldız S, Sütcüoglu O, Güvercin FS, Uyar Göçün P, Özdemir N, Yazıcı O, Özet A. Bir Yücel K, et al. Among authors: ozet a. J Oncol Pharm Pract. 2024 Jan;30(1):210-214. doi: 10.1177/10781552231197808. Epub 2023 Aug 29. J Oncol Pharm Pract. 2024. PMID: 37642988
173 results